Search results
Results from the WOW.Com Content Network
The "Javits New York Medical Station", a field hospital set up in the Javits Center, April 2020 during the COVID-19 pandemic. In March 2020, amid the COVID-19 pandemic in New York City , the Javits Center was adapted for use as a temporary 2,000-bed alternate care site to treat COVID-19 patients, [ 77 ] [ 78 ] [ 79 ] though the number of beds ...
This is the current logo of the Javits Center, from their website. This image or logo only consists of typefaces, individual words, slogans, or simple geometric shapes. These are not eligible for copyright alone because they are not original enough , and thus the logo is considered to be in the public domain .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jacob_Javits_Convention_Center&oldid=836647551"
In August 2020, the U.S. Food and Drug Administration (FDA) became aware of nitrosamine impurities in certain samples of rifampin. [62] The FDA and manufacturers are investigating the origin of these impurities in rifampin, and the agency is developing testing methods for regulators and industry to detect the 1-methyl-4-nitrosopiperazine (MNP ...
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jacob_Javits_Center&oldid=836647639"This page was last edited on 16 April 2018, at 01:01
Isoniazid/rifampicin, also known as isoniazid/rifampin, is a medication used to treat tuberculosis. [1] It is a fixed dose combination of isoniazid and rifampicin (rifampin). [1] It is used together with other antituberculosis medication. [1] It is taken by mouth. [1] It is on the World Health Organization's List of Essential Medicines. [2]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate